SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors aggressively position themselves ahead of the upcoming SpaceX IPO, viewing the company as a high-leverage "space-tug" infrastructure play with a low market cap. The community is heavily focused on the company's recent debt retirement, insider accumulation, and critical orbital successes, with active discussions centering on the potential for a short squeeze due to limited float.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending as investors weigh significant long-term growth potential from its nuclear reactor pipeline for AI data centers against near-term concerns regarding high cash burn and recent equity offerings. The community is focused on upcoming critical milestones, particularly the July 4th criticality target, while debating whether the current share price offers an attractive entry or further downside risk before commercial operations begin.

Sidus Space, Inc. is a space-as-a-service company. The firm focuses on commercial satellite design, manufacture, launch planning, mission operations and in-orbit support, and data collection with a vision to demonstrate space operations for new technologies, and deliver data and predictive analytics to both domestic and global customers. The company was founded by Carol M. Craig on July 17, 2012 and is headquartered in Merritt Island, FL.

Sidus Space Inc - Ordinary Shares - Class A

Sidus Space is trending due to intense speculation surrounding its position as a high-leverage, low-float play in the aerospace sector ahead of the highly anticipated SpaceX IPO. The community is heavily focused on the stock's potential for a major technical breakout, with discussions centering on its recent operational updates, institutional accumulation, and the belief that the broader space economy is reaching an inflection point.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is currently a major focus of community debate as investors weigh significant AI infrastructure partnerships in India and Thailand against concerns regarding the company's long-term financing strategy and potential dilution. While some traders are closely watching institutional capital management developments to gauge future growth, others remain skeptical about the speed of revenue conversion and the timing of official earnings reports.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASP Isotopes is experiencing high volatility as investors track critical production milestones for Silicon-28 and Helium while monitoring a potential spin-off of its Quantum Leap Energy subsidiary. The community remains divided, with sentiment split between frustration over delayed delivery timelines and aggressive optimism fueled by significant institutional accumulation and the stock's role in the strategic nuclear and quantum computing supply chain.

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF (NASA) is trending as retail investors seek accessible exposure to the upcoming SpaceX IPO through its specialized holdings. Community members are actively debating the ETF's inclusion of private SpaceX assets versus holding individual space stocks like Rocket Lab and AST SpaceMobile as the sector builds momentum around major launch milestones.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is seeing significant volatility as market participants debate its long-term AI-driven growth potential versus temporary sector rotation pressures. The community remains highly polarized, with many investors highlighting strong institutional buy-in and endorsements from industry leaders while others closely monitor technical support levels amidst broader software sector instability.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space is gaining attention as investors weigh the company's recent strategic partnerships and infrastructure developments against concerns over its cash runway, lack of current revenue, and ongoing internal legal disputes. The community remains deeply polarized, with some bulls highlighting the potential of its Mach 2+ flight platform ahead of the upcoming SpaceX IPO, while bears point to persistent dilution risks, the company's limited financial stability, and the pending departure of insider share lockups.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

SOXS is experiencing extreme volatility as traders weigh the potential for a semiconductor sector correction against ongoing AI-driven market momentum. Investors are actively debating the impact of upcoming major earnings reports, government policy, and geopolitical developments, leading to a high-stakes environment for those hedging against chip sector gains.

Ferrari NV is a holding company, which engages in the design, engineering, production, and sale of luxury sports cars. The firm's models include the F12Berlinetta, 488GTB, 488 Spider, 458 Speciale, California T, the LaFerrari Hybrid, LaFerrari, and the FF four-wheel drive. It participates in car racing such as Formula One. The company was founded by Enzo Anselmo Ferrari in 1939 and is headquartered in Maranello, Italy.

Ferrari N.V.

Ferrari is currently trending as investors weigh its upcoming product strategy and capital market announcements against broader luxury sector headwinds. The community remains focused on the company's long-term brand power and margin stability, while closely monitoring the stock's recent volatility and technical support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CytomX Therapeutics (CTMX) Reports Q1 Loss, Beats Revenue Estimates

CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of +29.58% and +193.76%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Beats Revenue Estimates

Mirum Pharmaceuticals (MIRM) delivered earnings and revenue surprises of +3.47% and +8.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

CytomX Therapeutics (CTMX) Expected to Announce Quarterly Earnings on Thursday

CytomX Therapeutics (NASDAQ:CTMX) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-cytomx-therapeutics-inc-stock...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Rating of "Moderate Buy" from Analysts

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and nine have assigned...

Wall Street Zen Downgrades CytomX Therapeutics (NASDAQ:CTMX) to Strong Sell

Wall Street Zen lowered shares of CytomX Therapeutics from a "sell" rating to a "strong sell" rating in a research note on Saturday...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Crosses Below 50-Day Moving Average - Here's What Happened

CytomX Therapeutics (NASDAQ:CTMX) Share Price Passes Below 50-Day Moving Average - What's Next...

Traders Buy High Volume of CytomX Therapeutics Put Options (NASDAQ:CTMX)

CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) was the recipient of some unusual options trading activity on Thursday. Stock traders acquired 13,090 put options on the company. This...

CytomX Therapeutics (NASDAQ:CTMX) Stock Price Up 6.3%  - Time to Buy?

CytomX Therapeutics (NASDAQ:CTMX) Trading Up 6.3% - What's Next...

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Brokerages

Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the ten brokerages that are covering the stock, MarketBeat Ratings...

Immunome (IMNM) Moves 13.3% Higher: Will This Strength Last?

Immunome (IMNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Current Price	$3.76
Prev Close	$3.76
Open	$3.75
Dividend Yield	0.00%
50-Day Moving Average	$4.34
Beta	1.48
Avg. Volume	4.31M
PE Ratio	-10.34

52-Week High	$8.21
52-Week Low	$1.72
Market Capitalization	$818.56M
EPS (Annual)	-$0.1477
Price to Book	2.56
Revenue Per Employee	$1.1M

CTMX
CytomX Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest CTMX News

CTMXCytomX Therapeutics Inc